Monday, November 16, 2026 Vol. I · No. 4
Business · Via CNBC

Novo says Wegovy injection lowers BMI and obesity rates in children in trial

Wegovy is already approved to treat obesity in children ages 12 and older, but there are currently no approved medications for those under 12.

This is a brief. The reporting belongs to CNBC — read the complete story, with full context and credits, at the source.

Read the full story at CNBC ↗

cnbc.com

More from the Business desk